Reaction
Hyperthermia Malignant reporting signals
As of the last recalculation, Hyperthermia Malignant appears in 1,458 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is SEVOFLURANE (PRR 613.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sevoflurane | 287 | 613.5 | 635.6 |
| Rocuronium Bromide | 198 | 277.4 | 282.2 |
| Propofol | 397 | 212.8 | 215.1 |
| Midazolam | 131 | 81.4 | 81.8 |
| Midazolam Hydrochloride | 138 | 80.7 | 81.1 |
| Atropine Sulfate | 50 | 68.4 | 68.7 |
| Atropine | 36 | 63.6 | 63.8 |
| Cefazolin Sodium | 39 | 47.4 | 47.6 |
| Cefazolin | 27 | 43.0 | 43.2 |
| Fentanyl | 225 | 38.4 | 38.5 |
| Fentanyl Citrate | 39 | 32.0 | 32.1 |
| Norepinephrine | 22 | 29.8 | 29.9 |
| Norepinephrine Bitartrate | 23 | 23.2 | 23.2 |
| Lidocaine Hydrochloride | 68 | 16.8 | 16.9 |
| Lidocaine Hydrochloride And Epinephrine Bitartrate | 60 | 16.7 | 16.7 |
| Lidicaine | 54 | 16.3 | 16.3 |
| Burn Relief | 54 | 16.3 | 16.3 |
| Lidocaine Hydrochloride And Epinephrine | 54 | 16.3 | 16.3 |
| Lidocaine, Menthol | 54 | 16.1 | 16.1 |
| Acetylcysteine | 10 | 15.2 | 15.3 |
| Lidocaine 4% | 55 | 14.9 | 15.0 |
| Lidocaine | 55 | 14.0 | 14.0 |
| Haloperidol | 22 | 13.1 | 13.1 |
| Haloperidol Lactate | 22 | 12.9 | 12.9 |
| Valproate Sodium | 16 | 11.2 | 11.2 |
| 0Xygen | 37 | 11.0 | 11.0 |
| Oxygen | 37 | 11.0 | 11.0 |
| Misoprostol | 7 | 10.3 | 10.3 |
| Rasagiline Mesylate | 7 | 9.0 | 9.0 |
| Amphetamine | 5 | 8.7 | 8.7 |
| Remdesivir | 8 | 8.6 | 8.6 |
| Granisetron Hydrochloride | 6 | 8.2 | 8.2 |
| Bupivacaine | 5 | 7.7 | 7.7 |
| Granisetron | 5 | 6.8 | 6.8 |
| Tapentadol Hydrochloride | 15 | 6.5 | 6.5 |
| Paliperidone Palmitate | 9 | 4.0 | 4.0 |
| Vigabatrin | 4 | 3.9 | 3.9 |